Evidence map›Paper›PMID 42286765›Full record

ReviewBiomarker research2026

The dual balance of the cytokine network: key messengers of immune activation and triggers of cytokine storm.

Yixiao Zhang, Dezhi Guo, Yuanhang Zhou, Changli Wang, Guowei Su, Jie Huang, Yiwen Wan, Haoling Zhang, Haifang Wan, Lulong Bo and 1 more

Abstract readReview
In one paragraph

Review in Biomarker research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yixiao Zhang *Department of Anesthesiology, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, 310003, China.
Dezhi Guo *Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Yuanhang Zhou *Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Changli Wang *Faculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Guowei SuDepartment of Anesthesiology, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, 310003, China.
Jie HuangFaculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Yiwen WanFaculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China.
Haoling ZhangDepartment of Biomedical Sciences, Pusat Kanser Tun Abdullah Ahmad Badawi, Universiti Sains Malaysia, Kepala Batas Pulau Pinang, 13200, Malaysia. zhanghaolingedu@163.com.
Haifang WanDepartment of Anesthesiology, Zhejiang Hospital of Integrated Traditional Chinese and Western Medicine, Hangzhou, 310003, China. yb2218204@zju.edu.cn.
Lulong BoFaculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China. bartbo@smmu.edu.cn.
Wangzheqi ZhangFaculty of Anesthesiology, Changhai Hospital, Naval Medical University, Shanghai, 200433, China. zwzq001031@smmu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The cytokine network is the central regulatory system for intercellular communication within the immune system. Its proper function depends on the dynamic balance between pro-inflammatory and anti-inflammatory cytokines. Through complex positive and negative feedback loops, this balance precisely regulates the intensity and duration of immune responses, thereby playing a critical role in both physiological and pathological states. This review systematically summarizes the compositional features and classification framework of the cytokine network, as well as the mechanisms by which it maintains homeostasis under physiological conditions. It further examines the manifestations of cytokine network imbalance in diseases such as sepsis, psoriasis, rheumatoid arthritis, inflammatory bowel disease, and cancer. Available evidence suggests that these imbalances drive disease onset and progression primarily through cascade amplification of pro-inflammatory signaling, insufficient generation of anti-inflammatory signals, and aberrant epigenetic modification. These pathological changes are strongly influenced by factors such as infection, autoimmune dysregulation, and the tumor microenvironment (TME), together constituting the core pathological axis of "cytokine imbalance-immune dysregulation-disease progression." This review also summarizes current clinical strategies targeting the cytokine network, including monoclonal antibodies, Janus kinase (JAK) inhibitors, and emerging modalities such as bispecific antibodies and chimeric antigen receptor (CAR) cell therapy. In addition, it evaluates the clinical efficacy, potential risks, and future directions of these approaches. In summary, a deeper understanding of the binary balance within the cytokine network not only broadens our knowledge of immune regulation but also provides a theoretical basis and translational framework for the development of precision immune-targeted therapies.

Indexed as

Anti-inflammatory cytokinesCytokine networkCytokine stormImmune regulationPro-inflammatory cytokinesTargeted therapy

Identifiers

PMID42286765
PMCPMC13330234

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.